Sponsor Pipeline

Kure Cells, INC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-20 NCT07713459 A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07713459 A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or… Lymphoma Nonhodgkin Not Yet Recruiting
Phase 1
NCT07611149 Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma Multiple Myeloma in Relapse Not Yet Recruiting
Disease Areas
Multiple Myeloma (1) DLBCL (1)
Get alerts when Kure Cells, INC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free